Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection

Journal of Neuroinflammation

Ruth Gabizon²  Haim Ovadia²  Oded Abramsky²  Tehila Mayer-Sonnenfeld²  Herbert Budka¹  Romana Hoftberger¹  Yael Friedman-Levi² 

[1] Institute of Neurology, Medical University of Vienna, Vienna, Austria;Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

关键词: spinal cord;    PrPSc;    prion;    infiltrates;    immune cells;    EAE;    Brain;   

Others  :  1212708
DOI  :  10.1186/1742-2094-9-58

 received in 2011-12-27, accepted in 2012-03-21,  发布年份 2012

【 摘 要 】

Background

Prions, composed of a misfolded protein designated PrP^Sc, are infectious agents causing fatal neurodegenerative diseases. We have shown previously that, following induction of experimental autoimmune encephalomyelitis, prion-infected mice succumb to disease significantly earlier than controls, concomitant with the deposition of PrP^Sc aggregates in inflamed white matter areas. In the present work, we asked whether prion disease acceleration by experimental autoimmune encephalomyelitis results from infiltration of viable prion-infected immune cells into the central nervous system.

Methods

C57Bl/6 J mice underwent intraperitoneal inoculation with scrapie brain homogenates and were later induced with experimental autoimmune encephalomyelitis by inoculation of MOG_35-55 in complete Freund's adjuvant supplemented with pertussis toxin. Spleen and lymph node cells from the co-induced animals were reactivated and subsequently injected into naïve mice as viable cells or as cell homogenates. Control groups were infected with viable and homogenized scrapie immune cells only with complete Freund's adjuvant. Prion disease incubation times as well as levels and sites of PrP^Sc deposition were next evaluated.

Results

We first show that acceleration of prion disease by experimental autoimmune encephalomyelitis requires the presence of high levels of spleen PrP^Sc. Next, we present evidence that mice infected with activated prion-experimental autoimmune encephalomyelitis viable cells succumb to prion disease considerably faster than do mice infected with equivalent cell extracts or other controls, concomitant with the deposition of PrP^Sc aggregates in white matter areas in brains and spinal cords.

Conclusions

Our results indicate that inflammatory targeting of viable prion-infected immune cells to the central nervous system accelerates prion disease propagation. We also show that in the absence of such targeting it is the load of PrP^Sc in the inoculum that determines the infectivity titers for subsequent transmissions. Both of these conclusions have important clinical implications as related to the risk of prion disease contamination of blood products.

【 授权许可】

   
2012 Friedman-Levi et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Colby DW, Prusiner SB: Prions. Cold Spring Harb Perspect Biol 2011, 3(1):a006833.
• [2]Canello T, Frid K, Gabizon R, Lisa S, Friedler A, Moskovitz J, Gasset M: Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP. PLoS Pathog 2010, 6:e1000977.
• [3]Canello T, Friedman-Levi Y, Mizrahi M, Binyamin O, Cohen R, Frid K, Gabizon R: Copper is toxic to PrP ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease. Neurobiol Dis 2012, 45:1010-1017.
• [4]Aguzzi A: Prions and the immune system: a journey through gut, spleen, and nerves. Adv Immunol 2003, 81:123-171.
• [5]Kimberlin RH, Walker CA: Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol 1979, 89:551-562.
• [6]Eklund CM, Kennedy RC, Hadlow WJ: Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 1967, 117:15-22.
• [7]Fraser H, Dickinson AG: Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol 1978, 88:563-573.
• [8]Aguzzi A, Heppner FL, Heikenwalder M, Prinz M, Mertz K, Seeger H, Glatzel M: Immune system and peripheral nerves in propagation of prions to CNS. Br Med Bull 2003, 66:141-159.
• [9]Mohan J, Brown KL, Farquhar CF, Bruce ME, Mabbott NA: Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J Dermatol Sci 2004, 35:101-111.
• [10]Rosicarelli B, Serafini B, Sbriccoli M, Lu M, Cardone F, Pocchiari M, Aloisi F: Migration of dendritic cells into the brain in a mouse model of prion disease. J Neuroimmunol 2005, 165:114-120.
• [11]Mohan J, Bruce ME, Mabbott NA: Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin. Immunology 2005, 114:225-234.
• [12]Lasmezas CI, Cesbron JY, Deslys JP, Demaimay R, Adjou KT, Rioux R, Lemaire C, Locht C, Dormont D: Immune system-dependent and -independent replication of the scrapie agent. J Virol 1996, 70:1292-1295.
• [13]Rubenstein R, Merz PA, Kascsak RJ, Scalici CL, Papini MC, Carp RI, Kimberlin RH: Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. J Infect Dis 1991, 164:29-35.
• [14]Daude N: Prion diseases and the spleen. Viral Immunol 2004, 17:334-349.
• [15]Glatzel M, Giger O, Seeger H, Aguzzi A: Variant Creutzfeldt-Jakob disease: between lymphoid organs and brain. Trends Microbiol 2004, 12:51-53.
• [16]Heikenwalder M, Zeller N, Seeger H, Prinz M, Klohn PC, Schwarz P, Ruddle NH, Weissmann C, Aguzzi A: Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 2005, 307:1107-1110.
• [17]Ligios C, Sigurdson CJ, Santucciu C, Carcassola G, Manco G, Basagni M, Maestrale C, Cancedda MG, Madau L, Aguzzi A: PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 2005, 11:1137-1138.
• [18]Traugott U, Raine CS, McFarlin DE: Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol 1985, 91:240-254.
• [19]Steinman L, Zamvil SS: Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 2005, 26:565-571.
• [20]Friedman-Levi Y, Ovadia H, Hoftberger R, Einstein O, Abramsky O, Budka H, Gabizon R: Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis. J Virol 2007, 81:9942-9949.
• [21]Kovacs GG, Budka H: Molecular pathology of human prion diseases. Int J Mol Sci 2009, 10:976-999.
• [22]Beringue V, Adjou KT, Lamoury F, Maignien T, Deslys JP, Race R, Dormont D: Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J Virol 2000, 74:5432-5440.
• [23]Ierna M, Farquhar CF, Outram GW, Bruce ME: Resistance of neonatal mice to scrapie is associated with inefficient infection of the immature spleen. J Virol 2006, 80:474-482.
• [24]Ben-Nun A, Mendel I, Bakimer R, Fridkis-Hareli M, Teitelbaum D, Arnon R, Sela M, Kerlero de Rosbo N: The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. J Neurol 1996, 243:S14-S22.
• [25]Outram GW: The pathogenesis of scrapie in mice. Front Biol 1976, 44:325-357.
• [26]Houston F, Foster JD, Chong A, Hunter N, Bostock CJ: Transmission of BSE by blood transfusion in sheep. Lancet 2000, 356:999-1000.
• [27]Eakin CM, Knight JD, Morgan CJ, Gelfand MA, Miranker AD: Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 2002, 41:10646-10656.